SCHEMBL4036629

SCHEMBL4036629

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2c(F)cccc2F)Nc2ccccc2N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.47
C3AR1 Q16581 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 2/20 0.42
MAPT P10636 1/20 0.41
TSHR P16473 3/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HSD17B10 Q99714 1/20 0.40
EPHX2 P34913 3/20 0.40
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
POLB P06746 1/20 0.39
EPHX1 P07099 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039455 0.89 KMT2A (0.48) NPC1RAB9AKMT2AMEN1C3AR1
SCHEMBL4044888 0.89 KMT2A (0.45) NPC1RAB9AKMT2AMEN1C3AR1
SCHEMBL4042940 0.85 TSHR (0.45) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4038973 0.84 NPC1 (0.46) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4040697 0.84 NPC1 (0.44) NPC1RAB9AKMT2AMEN1C3AR1
SCHEMBL4044511 0.84 EPHX2 (0.47) NPC1RAB9AKMT2AMEN1C3AR1
SCHEMBL4034552 0.83 NPC1 (0.41) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4041108 0.83 NPC1 (0.46) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4039445 0.82 CNR1 (0.42) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL4044809 0.82 NPC1 (0.46) NPC1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed